期刊文献+

检测病变组织中CD146、MMP-9及TIMP-2对完全性葡萄胎恶变的预测价值

Detection of CD146,MMP-9 and TIMP-2 and their prognostic value in malignant transformation of complete hydatidiform mole
下载PDF
导出
摘要 目的探讨黏附分子CD146、基质金属蛋白酶9(MMP-9)及基质金属蛋白酶抑制剂2(TIMP-2)的表达对完全性葡萄胎恶变的预测价值。方法采用免疫组化二步法检测80例完全性葡萄胎(恶变组36例,未恶变组44例)组织中CD146、MMP-9及TIMP-2的表达,分析其对完全性葡萄胎恶变的预测价值。结果完全性葡萄胎恶变组中CD146、MMP-9的表达明显高于未恶变组,P均<0.01;TIMP-2在两组中的表达相近(P>0.05)。联合检测CD146、MMP-9的表达对完全性葡萄胎恶变的阳性预测值和阴性预测值分别为84.1%和72.2%。结论CD146和MMP-9对完全性葡萄胎恶变的预测有一定价值,TIMP-2无预测价值。 [ Objective] To investigate the prognostic value of cell adhesion molecule CD146, matrix metalloproteinase (MMP) -9 and tissue inhibitor of metalloproteinases (TIMP) -2 in malignant transformation of complete hydatidiform mole. [ Methods] The expressions of CD146, MMP - 9 and TIMP - 2 was detected by immunohistochemistry in 80 cases of complete hydatidiform mole. The prognostic value was analyzed in malignant transformation of complete mole . [ Results ] The expression of CD146 and MMP - 9 was remarkably elevated in 36 cases of malignant transforming mole compared to 44 cases of non -malignant transforming mole (P 〈 0.01, respectively) , while there was no significant difference in TIMP -2 expression (P 〉 0.05). When the expressions of CD146 and MMP - 9 was used, the positive predictive value was 84.1% and the negative predictive value was 72.2% to the malignant transformation of complete hydatidiform mole. [ Conclusion] The increased expressions of CD146 and MMP - 9 are strong predictors for the malignant transformation of complete hydatidiform mole, while TIMP -2 has no predictive value.
出处 《山东医药》 CAS 北大核心 2007年第24期1-2,共2页 Shandong Medical Journal
基金 国家自然科学基金(30371478) 山东省优秀中青年科学家基金(03-BS021)。
关键词 细胞黏附分子 基质金属蛋白酶 基质金属蛋白酶抑制剂 葡萄胎 cell adhesion molecule matrix metalloproteinase tissue inhibitors of metalloproteinase hydatidiform mole
  • 相关文献

参考文献4

二级参考文献50

  • 1Shih IM, Schnaar RL, Gearhart JD, et al. Distribution of cells bearing the HNK-1 epitope in the human placenta. Placenta, 1997, 18(8):667-674.
  • 2Damsky CH, Fisher SJ. Trophoblast pseudovasculogenesis: faking it with endothelial adhesion receptors. Curt Opin Cell Biol, 1995, 10:660-666.
  • 3Zhou Y, Fisher SJ, Janatpour M, et al. Human cytotrophoblasts adopt a vascular phenotype as they differentiate: A atrategy for successful endovascular invasion? J Clin Invest, 1997, 99:2139-2151.
  • 4Choy MY, Manyonda IT. The phagocytic activity of human first trimester extravillous trophoblast. Hum Reprod, 1998, 13(10):2941-2949.
  • 5Shih IEM, Hsu MY, Oldt RJ, et al. The Role of E-eadherin in the Motility and Invasion of Implantation Site Intermediate Trophoblast.Placenta, 2002, 23( 10):706-715.
  • 6Xu G, Guimond MJ, Chakraborty C, et al. Control of proliferation, migration, and invasiveness of human extravillous trophoblast by decorin,a decidual product. Biol Reprod, 2002, 67(2):651-659.
  • 7Caniggia I, Grisaru Gravnosky S. Inhibition of TGF-beta3 restores the invasive capability of extravillous trophoblasts in preeclamptic pregnancies. J Clin Invest, 1999, 103(12):1641-1650.
  • 8Yudate T, Isaka K, Kosugi Y, et al. Analysis of the mechanism of trophoblast infiltration. Nippon Sanka Fujika Gakkai Zasshi, 1996, 48(3):191-198.
  • 9Kabir-Salmani M, Shiokawa S. alpha(v)beta(3) integrin signaling pathway is involved in insulin-like growth factor I-stimulated human extravillous trophoblast cell migration. Endocrinology, 2003, 144(4):1620-1630.
  • 10McKinnon T, Chakraborty C, Lala PK, et al. Stimulation of human extravillous trophoblast migration by IGF-II is mediated by IGF type 2 receptor involving inhibitory G protein (S) and phosphorylation of MAPK. J Clin Endocrinol Metab, 2001, 86(8):3665-3674.

共引文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部